. 2006 May 11;2006(4):93253. doi: 10.1155/MI/2006/93253

Table 2.

Analysis of serum liver fibrosis indexes. Data are presented as mean ± standard error of the mean. N represented the normal control group; M represented the model group; L represented the group treated with low dose of thalidomide; H represented the group treated with high dose of thalidomide.


Groups	n	HA(ng/mL)	LN(ng/mL)	PCIII(ng/mL)	C IV(ng/mL)
N	15	109.13 ± 15.92	31.89 ± 1.63	7.23 ± 1.37	26.93 ± 3.17
M	10	384.87 ± 15.91^a	86.40 ± 2.89^a	73.97 ± 1.96^a	51.53 ± 2.39^a
L	12	373.34 ± 8.66^a	85.34 ± 1.20^a	72.63 ± 1.14^a	49.33 ± 2.44^a
H	14	129.01 ± 12.81^ab ^c	35.26 ± 2.23^ab ^c	31.46 ± 3.13^ab ^c	31.25 ± 2.20^ab ^c

^aP < .01 versus normal control group; ^bP < .01 versus model group;

^cP < .01 group treated with low dose of thalidomide versus group treated with high dose of thalidomide.